These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31227392)

  • 1. Prevalence and Clinical Correlates of Extended Mechanical Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention in Current Clinical Practice: Insights from the cVAD Registry.
    Davila CD; Sharma S; Krishnamoorthy P; Rengifo-Moreno P; Palacios IF; O'Neill W; Kapur NK; Witzke CF
    Cardiovasc Revasc Med; 2020 Mar; 21(3):342-347. PubMed ID: 31227392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Azzalini L; Johal GS; Baber U; Bander J; Moreno PR; Bazi L; Kapur V; Barman N; Kini AS; Sharma SK
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E26-E33. PubMed ID: 32333721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    O'Neill BP; Grines C; Moses JW; Ohman EM; Lansky A; Popma J; Kapur NK; Schreiber T; Mannino S; O'Neill WW; Medjamia AM; Mahmud E
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):E501-E512. PubMed ID: 34051033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention.
    Reddy P; Merdler I; Zhang C; Cellamare M; Ben-Dor I; Bernardo NL; Hashim HD; Satler LF; Rogers T; Waksman R
    Am J Cardiol; 2024 Aug; 225():4-9. PubMed ID: 38871158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Alraies MC; Kaki A; Kajy M; Blank N; Hasan R; Htun WW; Glazier JJ; Elder M; O'Neill WW; Grines CL; Schreiber T
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):536-544. PubMed ID: 31631515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
    Vetrovec GW; Anderson M; Schreiber T; Popma J; Lombardi W; Maini B; Moller JE; Schäfer A; Dixon SR; Hall S; Ohman EM; Mindrescu C; Moses J; O'Neill W
    Am Heart J; 2018 May; 199():115-121. PubMed ID: 29754648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Tarantini G; Masiero G; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Mojoli M; Casu G; Giustino G; Lorenzoni G; Montorfano M; Ancona MB; Pappalardo F; Chieffo A;
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E222-E234. PubMed ID: 33793051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.
    Burzotta F; Russo G; Ribichini F; Piccoli A; D'Amario D; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Crea F; Trani C
    J Interv Cardiol; 2019; 2019():5243913. PubMed ID: 31772533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
    Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW
    J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudy.
    Ancona MB; Montorfano M; Masiero G; Burzotta F; Briguori C; Pagnesi M; Pazzanese V; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Casu G; Garbo R; Preti G; Nicolini E; Sclafani R; Colonna G; Mojoli M; Siviglia M; Denurra C; Caprioglio F; Scandroglio AM; Tarantini G; Chieffo A
    Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(9):999-1006. PubMed ID: 34389852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
    O'Neill WW; Schreiber T; Wohns DH; Rihal C; Naidu SS; Civitello AB; Dixon SR; Massaro JM; Maini B; Ohman EM
    J Interv Cardiol; 2014 Feb; 27(1):1-11. PubMed ID: 24329756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Flaherty MP; Moses JW; Westenfeld R; Palacios I; O'Neill WW; Schreiber TL; Lim MJ; Kaki A; Ghiu I; Mehran R
    Catheter Cardiovasc Interv; 2020 May; 95(6):1111-1121. PubMed ID: 31355987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function.
    Alaswad K; Basir MB; Khandelwal A; Schreiber T; Lombardi W; O'Neill W
    Am J Cardiol; 2018 Mar; 121(6):703-708. PubMed ID: 29370923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women With Cardiogenic Shock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry.
    Joseph SM; Brisco MA; Colvin M; Grady KL; Walsh MN; Cook JL;
    J Interv Cardiol; 2016 Jun; 29(3):248-56. PubMed ID: 27229327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Abu-Much A; Grines CL; Chen S; Batchelor WB; Zhao D; Falah B; Maini AS; Redfors B; Bellumkonda L; Bharadwaj AS; Moses JW; Truesdell AG; Zhang Y; Zhou Z; Baron SJ; Lansky AJ; Basir MB; O'Neill WW; Cohen DJ
    Int J Cardiol; 2024 Dec; 417():132555. PubMed ID: 39270940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience.
    Brandão M; Caeiro D; Pires-Morais G; Almeida JG; Teixeira PG; Silva MP; Ponte M; Dias A; Oliveira M; Rodrigues A; Braga P
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):853-861. PubMed ID: 34857158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL).
    Pietrasik A; Gąsecka A; Pawłowski T; Sacha J; Grygier M; Bielawski G; Balak W; Sukiennik A; Burzyńska P; Witkowski A; Warniełło M; Rzeszutko Ł; Bartuś S; Pawlik A; Kaczyński M; Gil R; Kuliczkowski W; Reczuch K; Protasiewicz M; Kleczyński P; Wańczura P; Gurba S; Kochanowska A; Łomiak M; Cacko A; Skorupski W; Zarębiński M; Pawluczuk P; Włodarczak S; Włodarczak A; Ściborski K; Telichowski A; Pluciński M; Hiczkiewicz J; Konsek K; Hawranek M; Gąsior M; Peruga J; Fiutowski M; Romanek R; Kasprzyk P; Ciećwierz D; Ochała A; Wojakowski W; Legutko J; Kochman J
    Kardiol Pol; 2023; 81(11):1103-1112. PubMed ID: 37937354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry.
    Chieffo A; Ancona MB; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Casu G; Giustino G; Montorfano M; Pappalardo F; Tarantini G;
    EuroIntervention; 2020 Feb; 15(15):e1343-e1350. PubMed ID: 31422925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex High-Risk Indicated Percutaneous Coronary Intervention With Prophylactic Use of the Impella CP Ventricular Assist Device.
    van den Buijs DMF; van den Brink FS; Wilgenhof A; Zivelonghi C; Verouden N; Knaapen P; Sjauw KD; Vermeersch P; Nap A
    J Invasive Cardiol; 2022 Sep; 34(9):E665-E671. PubMed ID: 36001456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roadmap towards an institutional Impella programme for high-risk coronary interventions.
    Pietrasik A; Gąsecka A; Jasińska-Gniadzik K; Szwed P; Grygier M; Pawłowski T; Sacha J; Kochman J
    ESC Heart Fail; 2023 Aug; 10(4):2200-2213. PubMed ID: 37345215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.